Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT05495152 · RECRUITING

Trial details

NCT number: NCT05495152
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2022-08-01
Primary completion: 2025-08-31
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.